A Chicago company has pleaded guilty in federal court in Abingdon to marketing a drug to elderly patients that was not approved by the FDA. Abbott Laboratories will pay 1.5 billion dollars for marketing Depakote (dep-uh-coat) to patients with dementia. The company will pay 700 million in fines and penalties and another 800 million to settle four civil cases in Virginia. (jb)